Navigation Links
Study points out inequalities in prescribing blood pressure meds
Date:2/18/2014

Primary care doctors are not quick to prescribe antihypertensive medication to young people even after an average of 20 months of high blood pressure. Young adults who are white, male, not on Medicaid and not frequent clinic visitors are especially less likely to receive medication. These are the results of a study by a research team at the University of Wisconsin School of Medicine and Public Health in the United States led by Heather Johnson. It appears in the Journal of General Internal Medicine, published by Springer.

One in every 10 Americans between the ages of 18 and 39 years old suffers from hypertension. Previous research has shown that young adults with hypertension are less likely to receive blood pressure medication than middle-aged and older adults because of lack of healthcare access. Because hypertension in young adulthood increases the risk of future cardiovascular events, medical treatment is advised if a patient's blood pressure isn't lowered through lifestyle modifications. Previous studies have also shown that medication can help control hypertension among young adults better and faster than is the case for older adults.

Johnson's team set about comparing rates and predictors of when young, middle-aged and older adults who make regular primary care visits are put onto antihypertensive medication. They analyzed the records of more than 10,000 adults older than 18 years who visited a large, Midwestern practice from 2008 to 2011.

They found that doctors were 44 percent slower in starting young adults (between the ages of 18 and 39 years old) on hypertension medication than they were for people aged 60 years and older. Males had a 36 percent slower rate of first receiving antihypertensive medication than women, while white patients were also less likely to receive such treatment. The research team believes the latter may be the case because of primary care providers who are responding to the known increased
'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Blood test serves as crystal ball for heart transplant patients, UCLA-led study finds
2. Study uncovers surprising differences in brain activity of alcohol-dependent women
3. Tinnitus study signals advance in understanding link between loud sounds exposure and hearing loss
4. Pregnancy study leads to fewer high birth weight babies
5. Metal implants may cut chemotherapy side effects, study suggests
6. New study explains how dense breast tissue drives the early stages of cancer
7. New UK study shows potential for targeting aggressive breast cancers
8. UNC study reveals potential route to bladder cancer diagnostics, treatments
9. Dartmouth study provides first global evidence that foreign aid boosts public opinion
10. Study: Resilience in parents of children undergoing stem cell transplant
11. Grant supports Cedars-Sinai study of possible links between air pollution and brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... UWDress.com sells cheap tall cocktail dresses worldwide ... Today, there is a new collection of tall cocktail ... offered at very low prices. It is really worthy ... launched by UWDress.com , UWDress.com is one of the ... company has the power to ensure customer satisfaction. Now, ...
(Date:11/28/2014)... York, NY (PRWEB) November 28, 2014 ... physical therapy techniques such as Dynamic Neuromuscular Stabilization, ... and gait/motion analysis. After moving to upgraded facilities ... and running clinic. Now, owner Dr. Lev Kalika ... performance and injury prevention lab in the country. ...
(Date:11/28/2014)... (PRWEB) November 29, 2014 The holiday season ... has recently announced its new collection of fashionable party dresses. ... 80% off, on all these brand new outfits; the special ... is a renowned online supplier and it has received ... company’s new items are specially designed to flatter various body ...
(Date:11/28/2014)... November 28, 2014 Brosix is always ... of providing users with a more efficient, effective, and ... of upgrades, including: , 1. The ability to setup ... allow Brosix to better service customers around the globe. ... of servers for large customers that require millions of ...
(Date:11/28/2014)... Novatus, a leading provider of contract ... provides customers with greater reporting capabilities, more searchable ... we continue to evolve and grow the Novatus ... improved performance in response to requests from our ... the enhancements that we have made to Advanced ...
Breaking Medicine News(10 mins):Health News:Graceful Tall Cocktail Dresses With New Features Just Added To UWDress.com 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 3Health News:Trendy Party Dresses For The Coming Holiday Season From Balfleet.com 2Health News:Brosix Infrastructure Architecture Changes to Benefit Users 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2
... to hold the, line on health care cost increases. ... RAPIDS, Mich., Feb. 15 Experts predict,health care costs ... impact of,these increases will have a major effect on ... while others are competing globally,for high tech talent. What ...
... part of new parent company for ... Batesville Casket Company, Stand alone medical technology ... doing business under well-known Hill-Rom brand, ... announced today that it has begun mailing a,notice regarding a special shareholder ...
... masses, study finds , , FRIDAY, Feb. 15 (HealthDay News) ... of two types of hard-to-treat pediatric tumors without harming ... viral therapy, dubbed rQT3, slowed neuroblastoma and peripheral nerve ... the Feb. 15 issue of Cancer Research . ...
... Calif., Feb. 15 Anti-Aging Formulas LLC,( http://www.renuva.net ... and,Mineral Spray, an oral spray with a proprietary ... multivitamin pills., Videos: ... "Unlike tablets, capsules and pills, our Daily ...
... Wis., Feb. 15 Nerites Corporation, a company,that ... medical,devices, today announced it has completed a $5.7 ... of Madison, Wisconsin, with participation by,Black Mountain Ventures ... had raised $3 million from private investors., ...
... specific antigen (PSA) test taken before the age of 50 ... up to 25 years in advance of a diagnosis, according ... Cancer Center in New York and Lund University in Sweden. ... Medicine, should help physicians be able to identify men who ...
Cached Medicine News:Health News:McGraw Wentworth Launches Survey to Benchmark Employee Benefit Trends in Michigan 2Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 2Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 3Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 4Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 5Health News:Viral Therapy Slows Pediatric Tumors in Mice 2Health News:New Renuva Daily Balance Spray Is Designed to Be the Easiest and Best Way to Take Daily Vitamins and Minerals 2Health News:Nerites Corporation Announces Closing of Series A Funding Round 2Health News:PSA testing can predict advanced prostate cancer 2
(Date:11/26/2014)... YORK , Nov. 26, 2014 ... growing at a rate of 4%, with world ... to Kalorama Information. MRI and other types of ... diagnosis and treatment of numerous medical conditions in ... technologies and techniques. Kalorama,s report, Medical Imaging ...
(Date:11/26/2014)... 25, 2014  At the American Dental Association,s Annual ... October, KaVo Kerr Group was honored to be part ... the opportunity to see and test the Best of ... deliver lectures on the latest developments in dental technology. ... new DEXIS CariVu Caries Detection Device and Kerr Demi ...
(Date:11/26/2014)... 25, 2014  Medtronic,s roughly $43 billion ... widely discussed in the media for its US ... stronger leading player in one of the fastest ... healthcare market research firm said  the two companies ... diverse set of solutions spanning inpatient to home ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3
... ViroPharma Incorporated (Nasdaq: VPHM ) today provided ... [Human]) manufacturing expansion activities.   , ... ViroPharma is increasing its Cinryze ... parallel chromatography process, was implemented earlier this year and allows ...
... , June 21, 2010 Zydus Cadila, a global,healthcare provider ... clinical trial permission from the DCGI for ZYOG1 - a novel,GLP-1 agonist. ... ZYOG1 is a novel, oral, anti-diabetic molecule. , ... The new class of anti-diabetic ...
Cached Medicine Technology:ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 2ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 3ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 4ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 5ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 6Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 2Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 3
A complete workstation for haemostasis , A compact and convenient analyser , A comprehensive system , An exellent reliability: the STAGO patented detection mode...
... Ophthalmic Products are constructed of ... lint-free MEROCEL polyvinyl acetal sponge. ... be beneficial to both surgeon ... and yet firm enough to ...
Tenderlett finger incision devices are designed to fit the contour of the finger. Tenderlett is available in three different incision depths from toddler to adult and color-code for easy identificat...
... Haemolance Plus Safety Lancets help protect ... needle stick injuries and cross-contamination. Designed ... for needlestick safety, the needle is ... The Haemolance Plus features automatic lockout ...
Medicine Products: